Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF V600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial
Titel:
Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF V600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial
Auteur:
Schreuer, Max Jansen, Yanina Planken, Simon Chevolet, Ines Seremet, Teofila Kruse, Vibeke Neyns, Bart